Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands

Pugliatti M, 2006, Eur J Neurol Official J Eur Fed Neurol Soc, 13, 700

Koutsouraki E, 2010, Int Rev Psychiatry, 22, 2, 10.3109/09540261003589216

Lalmohamed A, 2012, Eur J Neurol

Duddy M, 2011, J Neurol, 258, 28, 10.1007/s00415-011-6009-x

10.1016/j.euroneuro.2011.08.008

10.1177/1352458508092263

Johansson E, 2012, Mult Scler, 18, 17, 10.1177/1352458512441566a

Karampampa K, 2012, J Popul Ther Clin Pharmacol, 19, e11

Karampampa K, 2012, Mult Scler, 18, 35, 10.1177/1352458512441566d

Karampampa K, 2012, Mult Scler, 18, 23, 10.1177/1352458512441566b

Karampampa K, 2012, Mult Scler, 18, 29, 10.1177/1352458512441566c

Karampampa K, 2012, Mult Scler, 18, 41, 10.1177/1352458512441566e

10.1212/WNL.5.8.580

10.1007/s10198-006-0365-y

Kobelt G, 2006, Eur J Health Econ, 7, S55, 10.1007/s10198-006-0378-6

10.1136/jnnp.2006.090365

10.1016/S0140-6736(08)61620-7

Dolan P, 1995, A social tariff for EuroQol: results from a UK General Population Survey

Meads DM, 2009, Mult Scler, 15, 1228, 10.1177/1352458509106714

Minderhoud JM, 1994, Clin Neurol Neurosurg, 96, 135, 10.1016/0303-8467(94)90047-7

Karampampa K, 2012, Multe Scler, 18, 7, 10.1177/1352458512441566